Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atezolizumab plus platinum-based chemotherapy as neoadjuvant therapy for resectable stage II-IIIB non-small cell lung cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING